AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation

RecruitingNAAges 45 Years - 80 YearsAllSuperior University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial aims to compare the effectiveness of a Collaborative Virtual Reality Environment (CVE) and Non-Immersive Virtual Reality (NIVR) in the rehabilitation of patients with Parkinson's disease. Participants with mild to moderate disease severity will be randomly assigned to either the CVE group or the NIVR group. The CVE intervention will involve therapist-guided, interactive virtual exercises in a shared environment, promoting real-time engagement and feedback. The NIVR group will perform task-oriented exercises using screen-based virtual reality without immersive and collaborative features. Both interventions will be delivered over an 12-week period. Primary outcomes will assess motor function using standardized clinical scales, while secondary outcomes will evaluate cognitive function, mobility, and quality of life. The study seeks to determine whether co

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Male and Female * Age: 45 years-80 Years * Diagnosed patients of idiopathic Parkinson Disease with minor to moderate severity according to the Hoehn \& Yahr stages I-III. * On conventional and stable medical treatment at present * No severe cognitive impairments (MMSE โ‰ฅ 24). * Ability to participate in virtual rehabilitation sessions * Willingness to participate and provide informed consent Exclusion Criteria: * Severe visual, auditory, or motor impairments unrelated to Parkinson's. * Fear of virtual environment. * Comorbidities that hinder participation in the treatment (e.g., advanced dementia). * Severe musculoskeletal conditions limiting movement * History of epilepsy or conditions contraindicating virtual reality exposure * Participation in another interventional study within the last 3 months
๐Ÿ’Š

What it tests

  • Collaborative Virtual Environment
  • Non-Immersive Virtual Reality (NIVR)
๐Ÿ“

Where

1 site
Punjab Institute of Neurosciences Lahore
Lahore, Pakistan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy